Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 5 of 5 entries
Sorted by: Best Match Show Resources per page
Genome-wide mRNA and miRNA expression data analysis to screen for markers involved in sarcomagenesis in human chondrosarcoma cell lines.

Genomics data

Issac B, Galoian K, Guettouche T, Navarro L, Temple HT.
PMID: 26484120
Genom Data. 2014 Oct 13;2:320-4. doi: 10.1016/j.gdata.2014.10.001. eCollection 2014 Dec.

Genes and miRNAs involved in sarcomagenesis related pathways are unknown and therefore signaling events leading to mesenchymal cell transformation to sarcoma are poorly elucidated. Exiqon and Illumina microarray study on human chondrosarcoma JJ012 and chondrocytes C28 cell lines to...

Cite
Issac B, Galoian K, Guettouche T, et al. Genome-wide mRNA and miRNA expression data analysis to screen for markers involved in sarcomagenesis in human chondrosarcoma cell lines. Genom Data. 2014;2:320-4doi: 10.1016/j.gdata.2014.10.001.
Issac, B., Galoian, K., Guettouche, T., Navarro, L., & Temple, H. T. (2014). Genome-wide mRNA and miRNA expression data analysis to screen for markers involved in sarcomagenesis in human chondrosarcoma cell lines. Genomics data, 2320-4. https://doi.org/10.1016/j.gdata.2014.10.001
Issac, Biju, et al. "Genome-wide mRNA and miRNA expression data analysis to screen for markers involved in sarcomagenesis in human chondrosarcoma cell lines." Genomics data vol. 2 (2014): 320-4. doi: https://doi.org/10.1016/j.gdata.2014.10.001
Issac B, Galoian K, Guettouche T, Navarro L, Temple HT. Genome-wide mRNA and miRNA expression data analysis to screen for markers involved in sarcomagenesis in human chondrosarcoma cell lines. Genom Data. 2014 Oct 13;2:320-4. doi: 10.1016/j.gdata.2014.10.001. eCollection 2014 Dec. PMID: 26484120; PMCID: PMC4536178.
Copy Download .nbib Format: NLM
Improved coverage and accuracy with strand-conserving sequence enrichment.

Genome medicine

Guettouche T, Zuchner S.
PMID: 23731654
Genome Med. 2013 May 29;5(5):46. doi: 10.1186/gm450. eCollection 2013.

UNLABELLED: Targeted next-generation sequencing is becoming a common tool in the molecular diagnostic laboratory. However, currently available methods to enrich for regions of interest in the DNA sequence suffer from drawbacks such as high cost, complex protocols, lack of...

Cite
Guettouche T, Zuchner S. Improved coverage and accuracy with strand-conserving sequence enrichment. Genome Med. 2013;5(5):46doi: 10.1186/gm450.
Guettouche, T., & Zuchner, S. (2013). Improved coverage and accuracy with strand-conserving sequence enrichment. Genome medicine, 5(5), 46. https://doi.org/10.1186/gm450
Guettouche, Toumy, and Zuchner, Stephan. "Improved coverage and accuracy with strand-conserving sequence enrichment." Genome medicine vol. 5,5 (2013): 46. doi: https://doi.org/10.1186/gm450
Guettouche T, Zuchner S. Improved coverage and accuracy with strand-conserving sequence enrichment. Genome Med. 2013 May 29;5(5):46. doi: 10.1186/gm450. eCollection 2013. PMID: 23731654; PMCID: PMC3706846.
Copy Download .nbib Format: NLM
Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01.

EClinicalMedicine

Weiner J, Suwalski P, Holtgrewe M, Rakitko A, Thibeault C, Müller M, Patriki D, Quedenau C, Krüger U, Ilinsky V, Popov I, Balnis J, Jaitovich A, Helbig ET, Lippert LJ, Stubbemann P, Real LM, Macías J, Pineda JA, Fernandez-Fuertes M, Wang X, Karadeniz Z, Saccomanno J, Doehn JM, Hübner RH, Hinzmann B, Salvo M, Blueher A, Siemann S, Jurisic S, Beer JH, Rutishauser J, Wiggli B, Schmid H, Danninger K, Binder R, Corman VM, Mühlemann B, Arjun Arkal R, Fragiadakis GK, Mick E, Comet C, Calfee CS, Erle DJ, Hendrickson CM, Kangelaris KN, Krummel MF, Woodruff PG, Langelier CR, Venkataramani U, García F, Zyla J, Drosten C, Alice B, Jones TC, Suttorp N, Witzenrath M, Hippenstiel S, Zemojtel T, Skurk C, Poller W, Borodina T, Pa-Covid SG, Ripke S, Sander LE, Beule D, Landmesser U, Guettouche T, Kurth F, Heidecker B.
PMID: 34490415
EClinicalMedicine. 2021 Oct;40:101099. doi: 10.1016/j.eclinm.2021.101099. Epub 2021 Sep 02.

BACKGROUND: Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, there has been increasing urgency to identify pathophysiological characteristics leading to severe clinical course in patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Human leukocyte antigen...

Cite
Weiner J, Suwalski P, Holtgrewe M, et al. Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01. EClinicalMedicine. 2021;40:101099doi: 10.1016/j.eclinm.2021.101099.
Weiner, J., Suwalski, P., Holtgrewe, M., Rakitko, A., Thibeault, C., Müller, M., Patriki, D., Quedenau, C., Krüger, U., Ilinsky, V., Popov, I., Balnis, J., Jaitovich, A., Helbig, E. T., Lippert, L. J., Stubbemann, P., Real, L. M., Macías, J., Pineda, J. A., Fernandez-Fuertes, M., Wang, X., Karadeniz, Z., Saccomanno, J., Doehn, J. M., Hübner, R. H., Hinzmann, B., Salvo, M., Blueher, A., Siemann, S., Jurisic, S., Beer, J. H., Rutishauser, J., Wiggli, B., Schmid, H., Danninger, K., Binder, R., Corman, V. M., Mühlemann, B., Arjun Arkal, R., Fragiadakis, G. K., Mick, E., Comet, C., Calfee, C. S., Erle, D. J., Hendrickson, C. M., Kangelaris, K. N., Krummel, M. F., Woodruff, P. G., Langelier, C. R., Venkataramani, U., García, F., Zyla, J., Drosten, C., Alice, B., Jones, T. C., Suttorp, N., Witzenrath, M., Hippenstiel, S., Zemojtel, T., Skurk, C., Poller, W., Borodina, T., Pa-Covid, S. G., Ripke, S., Sander, L. E., Beule, D., Landmesser, U., Guettouche, T., Kurth, F., & Heidecker, B. (2021). Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01. EClinicalMedicine, 40101099. https://doi.org/10.1016/j.eclinm.2021.101099
Weiner, January, et al. "Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01." EClinicalMedicine vol. 40 (2021): 101099. doi: https://doi.org/10.1016/j.eclinm.2021.101099
Weiner J, Suwalski P, Holtgrewe M, Rakitko A, Thibeault C, Müller M, Patriki D, Quedenau C, Krüger U, Ilinsky V, Popov I, Balnis J, Jaitovich A, Helbig ET, Lippert LJ, Stubbemann P, Real LM, Macías J, Pineda JA, Fernandez-Fuertes M, Wang X, Karadeniz Z, Saccomanno J, Doehn JM, Hübner RH, Hinzmann B, Salvo M, Blueher A, Siemann S, Jurisic S, Beer JH, Rutishauser J, Wiggli B, Schmid H, Danninger K, Binder R, Corman VM, Mühlemann B, Arjun Arkal R, Fragiadakis GK, Mick E, Comet C, Calfee CS, Erle DJ, Hendrickson CM, Kangelaris KN, Krummel MF, Woodruff PG, Langelier CR, Venkataramani U, García F, Zyla J, Drosten C, Alice B, Jones TC, Suttorp N, Witzenrath M, Hippenstiel S, Zemojtel T, Skurk C, Poller W, Borodina T, Pa-Covid SG, Ripke S, Sander LE, Beule D, Landmesser U, Guettouche T, Kurth F, Heidecker B. Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01. EClinicalMedicine. 2021 Oct;40:101099. doi: 10.1016/j.eclinm.2021.101099. Epub 2021 Sep 02. PMID: 34490415; PMCID: PMC8410317.
Copy Download .nbib Format: NLM
HPV in HIV-Infected Women: Implications for Primary Prevention.

Frontiers in oncology

McKenzie ND, Kobetz EN, Ganjei-Azar P, Rosa-Cunha I, Potter JE, Morishita A, Lucci JA, Guettouche T, Hnatyszyn JH, Koru-Sengul T.
PMID: 25161956
Front Oncol. 2014 Aug 12;4:179. doi: 10.3389/fonc.2014.00179. eCollection 2014.

BACKGROUND: There is growing evidence that human immunodeficiency virus (HIV)-infected women might have a different human papillomavirus (HPV) type distribution in cervical dysplasia specimens as compared to the general population. This has implications for primary prevention.OBJECTIVE: We aimed to...

Cite
McKenzie ND, Kobetz EN, Ganjei-Azar P, et al. HPV in HIV-Infected Women: Implications for Primary Prevention. Front Oncol. 2014;4:179doi: 10.3389/fonc.2014.00179.
McKenzie, N. D., Kobetz, E. N., Ganjei-Azar, P., Rosa-Cunha, I., Potter, J. E., Morishita, A., Lucci, J. A., Guettouche, T., Hnatyszyn, J. H., & Koru-Sengul, T. (2014). HPV in HIV-Infected Women: Implications for Primary Prevention. Frontiers in oncology, 4179. https://doi.org/10.3389/fonc.2014.00179
McKenzie, Nathalie Dauphin, et al. "HPV in HIV-Infected Women: Implications for Primary Prevention." Frontiers in oncology vol. 4 (2014): 179. doi: https://doi.org/10.3389/fonc.2014.00179
McKenzie ND, Kobetz EN, Ganjei-Azar P, Rosa-Cunha I, Potter JE, Morishita A, Lucci JA, Guettouche T, Hnatyszyn JH, Koru-Sengul T. HPV in HIV-Infected Women: Implications for Primary Prevention. Front Oncol. 2014 Aug 12;4:179. doi: 10.3389/fonc.2014.00179. eCollection 2014. PMID: 25161956; PMCID: PMC4130182.
Copy Download .nbib Format: NLM
MicroRNA alterations in Barrett's esophagus, esophageal adenocarcinoma, and esophageal adenocarcinoma cell lines following cranberry extract treatment: Insights for chemoprevention.

Journal of carcinogenesis

Kresty LA, Clarke J, Ezell K, Exum A, Howell AB, Guettouche T.
PMID: 22279419
J Carcinog. 2011;10:34. doi: 10.4103/1477-3163.91110. Epub 2011 Dec 22.

BACKGROUND: Aberrant expression of small noncoding endogenous RNA molecules known as microRNAs (miRNAs) is documented to occur in multiple cancer types including esophageal adencarcinoma (EAC) and its only known precursor, Barrett's esophagus (BE). Recent studies have linked dysregulation of...

Cite
Kresty LA, Clarke J, Ezell K, et al. MicroRNA alterations in Barrett's esophagus, esophageal adenocarcinoma, and esophageal adenocarcinoma cell lines following cranberry extract treatment: Insights for chemoprevention. J Carcinog. 2011;10:34doi: 10.4103/1477-3163.91110.
Kresty, L. A., Clarke, J., Ezell, K., Exum, A., Howell, A. B., & Guettouche, T. (2011). MicroRNA alterations in Barrett's esophagus, esophageal adenocarcinoma, and esophageal adenocarcinoma cell lines following cranberry extract treatment: Insights for chemoprevention. Journal of carcinogenesis, 1034. https://doi.org/10.4103/1477-3163.91110
Kresty, Laura A, et al. "MicroRNA alterations in Barrett's esophagus, esophageal adenocarcinoma, and esophageal adenocarcinoma cell lines following cranberry extract treatment: Insights for chemoprevention." Journal of carcinogenesis vol. 10 (2011): 34. doi: https://doi.org/10.4103/1477-3163.91110
Kresty LA, Clarke J, Ezell K, Exum A, Howell AB, Guettouche T. MicroRNA alterations in Barrett's esophagus, esophageal adenocarcinoma, and esophageal adenocarcinoma cell lines following cranberry extract treatment: Insights for chemoprevention. J Carcinog. 2011;10:34. doi: 10.4103/1477-3163.91110. Epub 2011 Dec 22. PMID: 22279419; PMCID: PMC3263009.
Copy Download .nbib Format: NLM
Showing 1 to 5 of 5 entries